QL Block in Laparoscopic Myomectomy
Key facts
- Who runs it
- Joseph Findley MD
- Where
- Beachwood, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 80 people, planned
- Started
- 24 Aug 2024
- Expected to end
- 3 Jul 2028
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Bupivacain
- Saline
- Record updated
- 11 September 2026
Who can take part
- Age
- 18 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Presence of uterine fibroids requiring surgical excision with preservation of the uterus
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Provision of signed and dated informed consent form
Who cannot take part
- Pre-existing diagnoses of anxiety or depression
- Pre-existing coagulopathies
- Pre-existing neuropathic or chronic pelvic pain
- Chronic opioid use
- Illiteracy due to inability to read and understand plain questionnaire
- Non-English speaking
- BMI >38
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Where in United States
- University Hospitals Ahuja Medical CenterBeachwood, United StatesContact: Catherine P Haering, BATaking people
About the trial
What the trial wants to find out
This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.
The 2 groups in the trial
- QL Block with BupivacaineTreatment being tested
Participants will get a QL block using 30cc Bupivacaine bilaterally in quadratus lumborum muscle (60cc total).
Treatment: Bupivacain
- ControlSham treatment, for comparison
Participants will get a sham injection of 30cc saline bilaterally in quadratus lumborum muscle (60cc total).
Treatment: Saline
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Quadratus Lumborum Block to Improve Postoperative Pain Management After Laparoscopic Myomectomies: a Double-blinded and Prospective Randomized Clinical Trial.
- Fit questions
- Built from NCT05979493, who can take part
- Record updated
- 11 September 2026